The International Pharmaceutical Federation (FIP) recently released a new handbook and knowledge and skills guide for pharmacists on tobacco cessation.
Systematic review and meta-analysis finds that patients using biosimilars have equivalent clinical responses and functional capacity compared with those using reference biologic drugs.